Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1405808

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1405808

India Nicotine Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Gums, Lozenges), By Strength (2 mg, 4 mg), By Distribution Channel (Online, Offline, Hospital Pharmacies, Retail Pharmacies), & Segment Forecasts, 2024 - 2030

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 5950
Printable PDF (5-User License)
USD 6950
Printable PDF (Enterprise License)
USD 8950

Add to Cart

India Nicotine Replacement Therapy Market Growth & Trends:

The India nicotine replacement therapy market size is expected to reach USD 75.74 million by 2030, registering a CAGR 12.56% from 2024 to 2030, according to a new study by Grand View Research, Inc. The substantially high magnitude of India's tobacco user base, regional socioeconomic disparities, and the significant financial burdens associated with tobacco use boost the nicotine replacement therapy market & its role in addressing these challenges. The growing awareness of these issues, supported by government initiatives and collaborative efforts, presents a substantial growth opportunity for NRT products in India.

The inclusion of NRT in the National List of Essential Medicines (NLEM) in September 2022 marks a significant milestone. This move is poised to enhance accessibility and affordability. However, price capping could slow down market growth. Rigorous tobacco scrutiny ads and regulations have contributed to increased awareness about the risks associated with smoking, prompting individuals to seek safer alternatives like NRT. India has a well-defined regulatory framework for pharmaceuticals and healthcare products, which can provide a clear pathway for the legal approval & distribution of NRTs. Moreover, existing tobacco control laws and regulations can create a favorable legal environment for adopting NRTs as a harm reduction strategy.

Widespread retail expansion is expected to improve the accessibility of NRT products in India. Expansion of the retail sector in India is enhancing the accessibility of NRT products. It goes beyond mere convenience, highlighting the profound impact of this expansion on affordability, awareness, and the broader effort to provide effective smoking cessation solutions to a wider range of consumers in India.

Due to the expansion, NRT products are accessible beyond urban centers, ensuring that individuals in semi-urban and rural areas can access these smoking cessation aids. In addition, it improves affordability by fostering competition among retailers, making NRT more cost-effective. Furthermore, the visible placement of NRT products in retail outlets enhances awareness and normalizes conversations about quitting smoking. The convenience of purchasing products locally or online aligns with the lifestyles of several individuals in India, reducing tobacco consumption.

Affordability has remained a persistent challenge in terms of accessibility to NRT, particularly for low-income individuals residing in rural India. This obstacle posed difficulties in effectively combating tobacco addiction among this demographic. Despite efforts to these products NRT more affordable, insurance coverage remains the leading challenge. The lack of adequate financial support continues to hinder the most vulnerable populations from accessing smoking cessation aids.

India Nicotine Replacement Therapy Market Report Highlights:

  • Based on product, gums dominated the market in 2023 due to increasing emphasis on NRTs and growing involvement of the government, and developments in the industry
  • Based on strength, 4 mg held the largest share of the market due to higher price of 4 mg products. Higher pricing is often seen as indicative of increased potency for heavy smokers, which appeals to consumers seeking more robust solutions to address their nicotine cravings and addiction
  • Based on distribution channel, the offline segment dominated the India nicotine replacement sector in 2023
  • Accessibility of NRT products in retail pharmacies reflects the commitment to public health and highlights the importance of making cessation aids readily available to those looking to overcome smoking addiction
Product Code: GVR-4-68040-163-1

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Segment Definitions
    • 1.1.1 Product Segment
    • 1.1.2 Strength Segment
    • 1.1.3 Distribution Channel Segment
  • 1.2 Regional Scope
  • 1.3 Estimates And Forecast Timeline
  • 1.4 Objectives
    • 1.4.1 Objective - 1
    • 1.4.2 Objective - 2
    • 1.4.3 Objective - 3
  • 1.5 Research Methodology
  • 1.6 Information Procurement
    • 1.6.1 Purchased Database
    • 1.6.2 Gvr's Internal Database
    • 1.6.3 Secondary Sources
    • 1.6.4 Primary Research
  • 1.7 Information Or Data Analysis
    • 1.7.1 Data Analysis Models
  • 1.8 Market Formulation & Validation
  • 1.9 Model Details
    • 1.9.1 Commodity Flow Analysis
  • 1.10 List Of Secondary Sources
  • 1.11 List Of Abbreviations
  • 1.12 Research Assumptions

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Strength And Distribution Channel Segment Snapshot
  • 2.3 Competitive Landscape Snapshot
  • 2.4 Penetration And Growth Prospect Mapping For Nicotine Replacement Therapy Products, 2023

Chapter 3 India Nicotine Replacement Therapy Market - State Analysis, 2018 - 2030 (USD Million)

  • 3.1 India
    • 3.1.1 Andhra Pradesh
    • 3.1.2 Bihar
    • 3.1.3 Chhattisgarh
    • 3.1.4 Goa
    • 3.1.5 Gujarat
    • 3.1.6 Haryana
    • 3.1.7 Himachal Pradesh
    • 3.1.8 Jharkhand
    • 3.1.9 Karnataka
    • 3.1.10 Kerala
    • 3.1.11 Madhya Pradesh
    • 3.1.12 Maharashtra
    • 3.1.13 Odisha
    • 3.1.14 Punjab
    • 3.1.15 Rajasthan
    • 3.1.16 Sikkim
    • 3.1.17 Tamil Nadu
    • 3.1.18 Telangana
    • 3.1.19 Uttar Pradesh
    • 3.1.20 Uttarakhand
    • 3.1.21 West Bengal
    • 3.1.22 Andaman And Nicobar Islands
    • 3.1.23 Chandigarh
    • 3.1.24 Dadra & Nagar Haveli And Daman & Diu
    • 3.1.25 Delhi
    • 3.1.26 Jammu And Kashmir
    • 3.1.27 Lakshadweep
    • 3.1.28 Puducherry
    • 3.1.29 Ladakh
    • 3.1.30 Northeast India

Chapter 4 India Nicotine Replacement Therapy Market Variables, Trends, And Scope

  • 4.1 Market Lineage Outlook
    • 4.1.1 Parent Market
  • 4.2 Market Dynamics
    • 4.2.1 Market Driver Analysis
      • 4.2.1.1 Large Tobacco User Base In India
      • 4.2.1.2 Rising Health Consciousness In India
      • 4.2.1.3 Widespread Retail Expansion
    • 4.2.2 Market Restraint Analysis
      • 4.2.2.1 Poor Awareness, High Cost, And Lack Of Insurance Coverage For Nrt In Rural Areas
      • 4.2.2.2 Preference For Traditional Remedies And Limited Availability & Variety Of Nrt Products In Rural Areas
  • 4.3 Business Environment Analysis
    • 4.3.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
    • 4.3.2 Industry Analysis - Porter's
    • 4.3.3 Regulatory & Reimbursement Scenario
    • 4.3.4 Epidemiology Analysis
    • 4.3.5 Market Innovation And Trend Analysis
    • 4.3.6 Consumer & Kol Insights

Chapter 5 India Nicotine Replacement Therapy Market Analysis, By City, 2018 - 2030 (Revenue, USD Million) (Volume, Skus In Millions)

  • 5.1 Bangalore
  • 5.2 Pune
  • 5.3 Kolkata
  • 5.4 Mumbai
  • 5.5 Ahmedabad
  • 5.6 Delhi Ncr
  • 5.7 Lucknow
  • 5.8 Visakhapatnam
  • 5.9 Chennai
  • 5.10 Hyderabad
  • 5.11 Thane
  • 5.12 Nagpur
  • 5.13 Bhubaneswar
  • 5.14 Jaipur
  • 5.15 Surat

Chapter 6 India Nicotine Replacement Therapy Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 6.1 India Nicotine Replacement Therapy Market: Product Movement Analysis
  • 6.2 India Nicotine Replacement Therapy Market Estimates & Forecast, By Product (USD Million)
    • 6.2.1 Gum
    • 6.2.2 Lozenges
    • 6.2.3 Others

Chapter 7 India Nicotine Replacement Therapy Market - Segment Analysis, By Strength, 2018 - 2030 (USD Million)

  • 7.1 India Nicotine Replacement Therapy Market: Strength Movement Analysis
  • 7.2 India Nicotine Replacement Therapy Market Estimates & Forecast, By Strength (USD Million)
    • 7.2.1 2 Mg
    • 7.2.2 4 Mg

Chapter 8 India Nicotine Replacement Therapy Market - Segment Analysis, By Distribution Channel, 2018 - 2030 (USD Million)

  • 8.1 India Nicotine Replacement Therapy Market: Distribution Channel Movement Analysis
  • 8.2 India Nicotine Replacement Therapy Market Estimates & Forecast, By Distribution Channel (USD Million)
    • 8.2.1 Online
    • 8.2.2 Offline
      • 8.2.2.1 Hospital Pharmacies
      • 8.2.2.2 Retail Pharmacies
      • 8.2.2.3 Others (Supermarkets & Other Modes)

Chapter 9 Competitive Landscape

  • 9.1 Company Categorization
  • 9.2 Participants' Overview
    • 9.2.1 Company Profiles
      • 9.2.1.1 Glenmark Pharmaceuticals Ltd.
      • 9.2.1.1.1 Company Overview
      • 9.2.1.1.2 Financial Performance
      • 9.2.1.1.3 Product Benchmarking
      • 9.2.1.1.4 Strategic Initiatives
      • 9.2.1.2 Fertin Pharma
      • 9.2.1.2.1 Company Overview
      • 9.2.1.2.2 Financial Performance
      • 9.2.1.2.3 Product Benchmarking
      • 9.2.1.2.4 Strategic Initiatives
      • 9.2.1.3 Rubicon Consumer Healthcare Pvt. Ltd.
      • 9.2.1.3.1 Company Overview
      • 9.2.1.3.2 Financial Performance
      • 9.2.1.3.3 Product Benchmarking
      • 9.2.1.3.4 Strategic Initiatives
      • 9.2.1.4 Johnson & Johnson Services, Inc.
      • 9.2.1.4.1 Company Overview
      • 9.2.1.4.2 Financial Performance
      • 9.2.1.4.3 Product Benchmarking
      • 9.2.1.4.4 Strategic Initiatives
      • 9.2.1.5 Rusan Pharma Ltd.
      • 9.2.1.5.1 Company Overview
      • 9.2.1.5.2 Financial Performance
      • 9.2.1.5.3 Product Benchmarking
      • 9.2.1.5.4 Strategic Initiatives
      • 9.2.1.6 Cipla, Inc.
      • 9.2.1.6.1 Company Overview
      • 9.2.1.6.2 Financial Performance
      • 9.2.1.9.2 Product Benchmarking
      • 9.2.1.6.4 Strategic Initiatives
      • 9.2.1.7 Piramal Pharma Limited
      • 9.2.1.7.1 Company Overview
      • 9.2.1.7.2 Financial Performance
      • 9.2.1.7.3 Product Benchmarking
      • 9.2.1.7.4 Strategic Initiatives
      • 9.2.1.8 Itc Limited
      • 9.2.1.8.1 Company Overview
      • 9.2.1.8.2 Financial Performance
      • 9.2.1.8.3 Product Benchmarking
      • 9.2.1.8.4 Strategic Initiatives
      • 9.2.1.9 Inventz Lifesciences
      • 9.2.1.9.1 Company Overview
      • 9.2.1.9.2 Financial Performance
      • 9.2.1.9.3 Product Benchmarking
      • 9.2.1.9.4 Strategic Initiatives
      • 9.2.1.10 Sparsha Pharma International Pvt. Ltd.
      • 9.2.1.10.1 Company Overview
      • 9.2.1.10.2 Financial Performance
      • 9.2.1.10.3 Product Benchmarking
      • 9.2.1.10.4 Strategic Initiatives
  • 9.3 Market Share Analysis
    • 9.3.1 India Nicotine Replacement Therapy Market Share Analysis, 2023
    • 9.3.2 India Nicotine Replacement Therapy Market Share Analysis, By Product (Gum), 2023
    • 9.3.3 India Nicotine Replacement Therapy Market Share Analysis, By Product (Lozenges), 2023
  • 9.4 Strategy Mapping
    • 9.4.1 Collaboration
    • 9.4.2 Acquisitions
    • 9.4.3 Others

Chapter 10 Conclusion

Product Code: GVR-4-68040-163-1

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 Tobacco Use Statistics in India, 2022
  • Table 4 India nicotine replacement therapy market revenue estimates and forecast, by product, 2018 - 2030 (USD Million)
  • Table 5 India nicotine replacement therapy market revenue estimates and forecast, by strength, 2018 - 2030 (USD Million)
  • Table 6 India nicotine replacement therapy market revenue estimates and forecast, by distribution channel, 2018 - 2030 (USD Million)
  • Table 7 Key companies undergoing collaboration
  • Table 8 Key companies undertaking acquisitions
  • Table 9 Key companies undergoing other strategies

List of Figures

  • Fig. 1 India Nicotine Replacement Therapy Market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value chain based sizing & forecasting
  • Fig. 7 QFD modelling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market snapshot
  • Fig. 10 Strength and distribution channel segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Andhra Pradesh market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Bihar market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Chhattisgarh market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 17 Goa market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 18 Gujarat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Haryana market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 20 Himachal Pradesh market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Jharkhand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Karnataka market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Kerala market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Madhya Pradesh market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Maharashtra market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Odisha market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Punjab market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Rajasthan market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 29 Sikkim market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 30 Tamil Nadu market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Telangana market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Uttar Pradesh market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 33 Uttarakhand market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 West Bengal market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Andaman and Nicobar Islands market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Chandigarh market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 37 Dadra & Nagar Haveli and Daman & Diu market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 38 Delhi market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Jammu and Kashmir market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Lakshadweep market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 41 Puducherry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 42 Ladakh market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Northeast India market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Market dynamics
  • Fig. 45 SWOT analysis, by factor (Political & legal, economic, and technological)
  • Fig. 46 Industry analysis - Porter's
  • Fig. 47 Bangalore market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Pune market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 49 Kolkata market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 50 Mumbai market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Ahmedabad market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Delhi NCR market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 53 Lucknow market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 54 Visakhapatnam market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 Chennai market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 56 Hyderabad market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 57 Thane market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Nagpur market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Bhubaneswar market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 60 Jaipur market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 61 Surat market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 India nicotine replacement therapy market: Product outlook and key takeaways
  • Fig. 63 India nicotine replacement therapy market: product movement analysis
  • Fig. 64 Gum market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 65 Lozenges market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 India nicotine replacement therapy market: Strength outlook and key takeaways
  • Fig. 68 India nicotine replacement therapy market: Strength movement analysis
  • Fig. 69 2 mg market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 4 mg market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 India nicotine replacement therapy market: Distribution channel outlook and key takeaways
  • Fig. 72 India nicotine replacement therapy market: Distribution channel movement analysis
  • Fig. 73 Online market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Offline market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 76 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Others (supermarkets & other modes) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 India nicotine replacement therapy market share analysis, 2023
  • Fig. 80 India nicotine replacement therapy market share analysis, by product 2023
  • Fig. 81 India nicotine replacement therapy market share analysis, by product 2023
  • Fig. 82 Strategic framework
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!